Mr. Tyler Burns reports

CANOPY GROWTH AND SPECTRUM THERAPEUTICS ANNOUNCE SPECTRUM RESERVE, A NEW PREMIUM MEDICAL CANNABIS BRAND

Canopy Growth Corp. has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation -- featuring flower selected for size, potency and terpene levels through rigorous in-house standards during cultivation and postharvest.

Under this new program, Spectrum Reserve is expected to introduce new strains on a regular basis based on patient needs, preferences and feedback. The strains which generate the most positive and consistent customer feedback will remain in market, while others will be phased out to make way for new genetics through a process of constant enhancement. This approach will help Spectrum Therapeutics consistently deliver new, premium quality strains to the medical cannabis market in Canada.

"By selecting only the genetics that deliver an elevated combination of THC and terpenes, Spectrum Reserve offers a cannabis experience that evolves through continuous innovation while consistently meeting the needs of medical cannabis patients," said Andrew Bevan, senior vice-president, medical sales, Canopy Growth. "This new Spectrum Reserve program reinforces our leadership in medical cannabis by combining industry-leading cultivation with a strong focus on premium quality."

The first release under the Spectrum Reserve brand features four flower strains, each selected for the combination of their potency and terpene profile:

1. Power Plant x Super Silver Haze (indica, 22 to 25 per cent THC): a rich, woody and earthy aroma, with a sharp, peppery taste and 2.21 per cent total terpenes;
2. Grape Star x Golden Lemons (sativa, 22 to 25 per cent THC): with a dank white grape aroma, this strain features 1.77 per cent total terpenes, offering a smooth, uplifting experience;
3. Malawi x Kosher Tangie (hybrid, 27 to 30 per cent THC): a complex citrus and chocolate flavour profile, complemented by a pungent, earthy aroma, with 2.59 per cent total terpenes;
4. Raspberry Parfait (sativa-dominant hybrid, 22 to 27 per cent THC): with 2.59 per cent total terpenes, this strain features a plum, berry and violet aroma for a rich and flavourful experience.

Patients registered with Spectrum Therapeutics can visit the Spectrum website to obtain more information on Spectrum Reserve flower strains.

About Canopy Growth Corp.

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.

Through an unwavering commitment to the company's consumers, Canopy Growth delivers innovative products with a focus on premium and mainstream cannabis brands including Tweed, 7Acres, DOJA, Deep Space and Claybourne, as well as category-defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.

Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the United States THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA's portfolio includes ownership of Acreage Holdings, a vertically integrated multistate cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Brands, a leading North American edibles brand, and majority ownership of Jetty Extracts, a California-based producer of high-quality cannabis extracts and clean vape technology.

At Canopy Growth, the company is shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where the company lives and works, the company is paving the way for a better understanding of all that cannabis can offer.